UnitedHealth 4Q Report: Stocks Dip Amid Surging Medical Costs
TL/DR -
UnitedHealth Group's Q4 results beat expectations, but was still hit by soaring medical costs, which increased by 16% to $62.23 billion. The rising costs were attributed to increased claims from its Medicare Advantage business and the impact of COVID-19, but the company remained confident that it wouldn't affect its expectations for 2024.…